CMR-Modeled PCWP Independent Risk Factor for Heart Failure
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 22, 2024 -- Elevated cardiovascular magnetic resonance (CMR) imaging-modeled pulmonary capillary wedge pressure (PCWP) is an independent risk factor for heart failure and major adverse cardiovascular events (MACE), according to a study published online Aug. 12 in ESC Heart Failure.
Ross J. Thomson, B.M.B.Ch., from Queen Mary University of London, and colleagues examined the prognostic value of CMR-modeled PCWP at the population level using data from the imaging substudy of the U.K. Biobank. A model incorporating left atrial volume, left ventricular mass, and sex was used to calculate CMR-modeled PCWP. The relationship between typical cardiovascular risk factors and elevated CMR-modeled PCWP (≥15 mmHg) was explored. The impact of typical risk factors and CMR-modeled PCWP was examined on heart failure and MACE.
The study included data from 39,163 participants (median age, 64 years). The researchers found that hypertension (odds ratio [OR], 1.57), body mass index (OR, 1.57 per standard deviation increment), male sex (OR, 1.37), age (OR, 1.33 per decade increment), and regular alcohol consumption (OR, 1.10) were clinical characteristics independently associated with elevated CMR-modeled PCWP. Independent, significant associations were seen for CMR-modeled PCWP with incident heart failure and MACE after adjustment for potential confounders.
"These findings may have implications for developing targeted screening strategies at the population level for heart failure," the authors write.
Several authors disclosed ties to the medical device and technology industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
MRI-Guided Biopsy Linked to Durability of Active Surveillance in Prostate Cancer
MONDAY, May 19, 2025 -- Use of magnetic resonance imaging (MRI)-guided biopsy (MRGB) could increase the durability of active surveillance (AS) in men with prostate cancer...
AI Tools Can Predict Left Ventricular Dysfunction in Women of Reproductive Age
WEDNESDAY, May 14, 2025 -- Artificial intelligence (AI) tools are effective for detecting left ventricular systolic dysfunction (LVSD) among women of reproductive age seen in...
Patients Mainly Prefer AI as Second Reader for Screening Mammogram
WEDNESDAY, April 23, 2025 -- Use of artificial intelligence (AI) as a second reader in screening mammography is accepted by patients, according to a study published online April...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.